| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.12 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |